4-Phenoxyaniline

4-Phenoxyaniline

SCHEMBL4630332

CC(=O)O.Nc1ccc(Oc2ccccc2)cc1

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of 4-Phenoxyaniline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.75
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
NPC1 O15118 2/20 0.60
RAB9A P51151 2/20 0.60
NLRP3 Q96P20 1/20 0.60
ALDH1A1 P00352 6/20 0.58
TDP1 Q9NUW8 2/20 0.58
TSHR P16473 2/20 0.58
CYP3A4 P08684 1/20 0.58
SMN1; SMN2 Q16637 4/20 0.57
MAPT P10636 3/20 0.57
MITF O75030 1/20 0.57
GAA P10253 1/20 0.57
GFER P55789 1/20 0.57
NLRP1 Q9C000 1/20 0.57
NOD2 Q9HC29 1/20 0.57
PARP10 Q53GL7 2/20 0.57
TEAD4 Q15561 1/20 0.54
POLB P06746 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
4-Phenoxyaniline SCHEMBL159084 0.87 MAOA (1.00) MAOAMEN1KMT2ANPC1RAB9A
Diphenylether SCHEMBL28089995 0.87 MAOA (1.00) MAOAMEN1KMT2ANPC1RAB9A
Diphenylether SCHEMBL29175285 0.87 LTA4H (0.67) RAB9ATSHRSMN1; SMN2MAPTPARP10
SCHEMBL554324 0.87 MAOA (1.00) MAOAMEN1KMT2ANPC1RAB9A
Diphenylether SCHEMBL1830446 0.87 LTA4H (0.67) RAB9ATSHRSMN1; SMN2MAPTPARP10
Acetic Acid SCHEMBL4630370 0.84 SMN1; SMN2 (0.81) MAOAMEN1KMT2ANPC1RAB9A
Diphenylether SCHEMBL8671677 0.84 LTA4H (0.63) RAB9ATSHRSMN1; SMN2MAPTPARP10
4-Phenoxyaniline SCHEMBL2830851 0.84 MAOA (0.95) MAOAMEN1KMT2ANPC1RAB9A
4-Phenoxyaniline SCHEMBL3318254 0.84 MAOA (0.69) MAOAMEN1KMT2ANPC1RAB9A
4-Phenoxyaniline SCHEMBL29256862 0.84 SRD5A2 (0.72) MAOAMEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919875-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS Astex Therapeutics Limited (GB) 2008-05-14 EP claimed
WO-2006136829-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 WO claimed
EP-1919875-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS Astex Therapeutics Limited (GB) 2008-05-14 EP disclosed
WO-2006136829-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 WO disclosed
EP-0721944-B1 IMIDAZOLIDINE DERIVATIVE AND USE THEREOF SUNTORY LTD (JP) 2001-01-17 EP disclosed
US-5691335-A CARDIOVASCULAR DISORDERS SUNTORY LIMITED (JP) 1997-11-25 US disclosed
EP-0721944-A1 IMIDAZOLIDINE DERIVATIVE AND USE THEREOF SUNTORY LIMITED (JP) 1996-07-17 EP disclosed